Bone Biologics annual depreciation and amortization
2014
2015
2016
2017
2018
2019
Bone Biologics Depreciation & Amortization Growth & History (BBLG)
Bone Biologics's depreciation and amortization was $50 for fiscal 2019.
View full Bone Biologics company overviewBone Biologics annual depreciation and amortization history
| Fiscal year | Period ended | Depreciation and amortization | Change | Growth |
|---|---|---|---|---|
| 2019 | 2019-12-31 | $50 | −$46 | −47.92% |
| 2018 | 2018-12-31 | $96 | $0 | 0.00% |
| 2017 | 2017-12-31 | $96 | −$604 | −86.29% |
| 2016 | 2016-12-31 | $700 | −$3,751 | −84.27% |
| 2015 | 2015-12-31 | $4,451 | $4,171 | +1489.64% |
| 2014 | 2014-12-31 | $280 | — | — |
Bone Biologics quarterly depreciation and amortization
Q1.14
Q1.15
Q2.15
Q3.15
Q1.16
Q2.16
Q3.16
Q1.17
Q2.17
Q3.17
Q1.18
Q2.18
Q3.18
Q1.19
Q2.19
Q3.19
| Fiscal quarter | Period ended | Depreciation and amortization | Change | YoY change |
|---|---|---|---|---|
| Q3 2019 | 2019-09-30 | $0 | −$24 | — |
| Q2 2019 | 2019-06-30 | $26 | $2 | +8.33% |
| Q1 2019 | 2019-03-31 | $24 | $0 | 0.00% |
| Q3 2018 | 2018-09-30 | $24 | $0 | 0.00% |
| Q2 2018 | 2018-06-30 | $24 | $0 | 0.00% |
| Q1 2018 | 2018-03-31 | $24 | $0 | 0.00% |
| Q3 2017 | 2017-09-30 | $24 | −$16 | −40.00% |
| Q2 2017 | 2017-06-30 | $24 | −$16 | −40.00% |
| Q1 2017 | 2017-03-31 | $24 | −$556 | −95.86% |
| Q3 2016 | 2016-09-30 | $40 | −$530 | −92.98% |
| Q2 2016 | 2016-06-30 | $40 | −$531 | −92.99% |
| Q1 2016 | 2016-03-31 | $580 | $9 | +1.58% |
| Q3 2015 | 2015-09-30 | $570 | — | — |
| Q2 2015 | 2015-06-30 | $571 | — | — |
| Q1 2015 | 2015-03-31 | $571 | $571 | — |
| Q1 2014 · Mar 31 | 2014-03-31 | $0 | — | — |
Bone Biologics depreciation and amortization trends
Over the last five fiscal years, Bone Biologics's depreciation and amortization decreased from $280 to $50, a change of −$230. The latest reported quarter, Q3 2019, shows $0.
About the metric
What depreciation and amortization mean
Depreciation and amortization allocate the cost of tangible and intangible assets over their useful lives. These non-cash expenses reduce reported earnings and are commonly added back when calculating EBITDA and operating cash flow.
Calculation and source
Reported depreciation and amortization
TickerStat uses a combined depreciation and amortization value when reported. If a company reports the two components separately for an aligned period, they are added together without duplicating overlapping facts. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Bone Biologics source filings ↗